Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Rosa & Co. LLC
SAN CARLOS, Calif., Jan. 23, 2014 /PRNewswire/ -- Rosa & Co. LLC (www.rosaandco.com) today announced the acquisition of the consulting service business of Entelos Holdings, Inc. (www.entelos.com), which conducts mechanistic, physiologic, in silico modeling projects for customers for the purpose of pharmaceutical research and development. The acquisition, which closed January 7, 2014, further extends Rosa's presence in quantitative systems pharmacology and modeling and simulation research services and adds to their already significant expertise in cardiovascular, immunology, and metabolism biology, and human nutrition. The transaction will also enable Entelos' clients an opportunity to access Rosa's flexible and participatory approach to developing customized PhysioPD™ Research Platforms. Rosa's PhysioPD Platforms employ a user-friendly, open-architecture modeling and simulation system that is interoperable with commonly used third-party software.
"We are thrilled to further strengthen our expertise in these key areas," said Rosa CEO Ron Beaver, PhD, "and have the opportunity to offer our proven approach to an expanded client base."
Rosa helps clients better understand complex biology and inform their critical decisions – from preclinical through clinical development – with the creation and use of flexible mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. Rosa offers both PhysioPD™ Research Platforms and classic pharmacokinetic/pharmacodynamic (PK/PD) models. Rosa's clients participate in customized model development and testing processes, retain the resulting models, and acquire the ability to perform simulation research to better understand implications for their pharmaceutical, consumer, and veterinary product development programs. Rosa has unparalleled experience in applying modeling and simulation to better understand biology and accelerate product development and is unique in its breadth and depth of disease area experience, including metabolic, cardiovascular, oncology, inflammation, immune dysfunction, CNS, respiratory, dermatology, nutrition, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.
For more information contact: Sharan Pagano, Email
Read more news from Rosa & Co. LLC
©2012 PR Newswire. All Rights Reserved.